Amyloid-&bgr; Immunotherapy for Alzheimer's Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 2, 2010-04 ,pp. : 197-206

Bentham Science Publishers

Access to resources Recommend Favorite

Complex Pharmacokinetics of a Humanized Antibody Against Human Amyloid Beta Peptide, Anti-Abeta Ab2, in Nonclinical Species

By Vugmeyster Yulia   Szklut Pam   Wensel David   Ross John   Xu Xin   Awwad Michel   Gill Davinder   Tchistiakov Lioudmila   Warner Garvin  

Pharmaceutical Research, Vol. 28, Iss. 7, 2011-07 ,pp. : 1696-1706

Springer Publishing Company

Access to resources Recommend Favorite

Chronological Age Impacts Immunotherapy and Monocyte Uptake Independent of Amyloid Load

By Li Qingyou  

Journal of Neuroimmune Pharmacology, Vol. 7, Iss. 1, 2012-03 ,pp. : 202-214

Springer Publishing Company

Access to resources Recommend Favorite

Pyroglutamate-Modified Amyloid Beta Peptides: Emerging Targets for Alzheimer´s Disease Immunotherapy

By  

Current Neuropharmacology, Vol. 11, Iss. 5, 2013-09 ,pp. : 491-498

Bentham Science Publishers

Access to resources Recommend Favorite

Soft Tissue Augmentation by Fibrosis: Fat Injections and Other Means

By FIELD LAWRENCE M.  

Dermatologic Surgery, Vol. 22, Iss. 2, 1996-02 ,pp. : 192-193

Elsevier

Access to resources Recommend Favorite